In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.
about
Inhibition of Mycobacterium tuberculosis Methionine Aminopeptidases by Bengamide DerivativesStructural and Functional Characterization of Rv2966c Protein Reveals an RsmD-like Methyltransferase from Mycobacterium tuberculosis and the Role of Its N-terminal Domain in Target RecognitionEnhancing hit identification in Mycobacterium tuberculosis drug discovery using validated dual-event Bayesian modelsChlorinated Coumarins from the Polypore MushroomFomitopsis officinalisand Their Activity againstMycobacterium tuberculosisMethyltransferase Erm(37) slips on rRNA to confer atypical resistance in Mycobacterium tuberculosis.Structure-activity relationships of compounds targeting mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate synthase.Targeting mycobacterium protein tyrosine phosphatase B for antituberculosis agents.Structure-activity relationship of new anti-tuberculosis agents derived from oxazoline and oxazole benzyl esters.Scaffold-switching: an exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates.Bioactive bromophycolides R-U from the Fijian red alga Callophycus serratus.Identification and characterization of novel inhibitors of mPTPB, an essential virulent phosphatase from Mycobacterium tuberculosis.Structure and biological evaluation of novel cytotoxic sterol glycosides from the marine red alga Peyssonnelia sp.Intrinsic macrolide resistance of the Mycobacterium tuberculosis complex is inducible.Biological evaluation of plants of Laos used in the treatment of tuberculosis in Lao traditional medicine.In vitro and in vivo activities of the nitroimidazole TBA-354 against Mycobacterium tuberculosisCombining computational methods for hit to lead optimization in Mycobacterium tuberculosis drug discovery.Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis ActivityNew finding of an anti-TB compound in the genus Marsypopetalum (Annonaceae) from a traditional herbal remedy of Laos.The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo.Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.In vitro and in vivo Evaluation of Synergism between Anti-Tubercular Spectinamides and Non-Classical Tuberculosis AntibioticsSynthesis, evaluation, and CoMFA study of fluoroquinophenoxazine derivatives as bacterial topoisomerase IA inhibitors.Resistance to ketolide antibiotics by coordinated expression of rRNA methyltransferases in a bacterial producer of natural ketolides.Evaluation of pseudopteroxazole and pseudopterosin derivatives against Mycobacterium tuberculosis and other pathogens.Syntheses of mycobactin analogs as potent and selective inhibitors of Mycobacterium tuberculosis.Natural product growth inhibitors of Mycobacterium tuberculosis.Antituberculosis cycloartane triterpenoids from Radermachera boniana.Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesisBenzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosisChemotherapeutic interventions against tuberculosisAntimalarial bromophycolides J-Q from the Fijian red alga Callophycus serratus.Treatment of tuberculosis in children.Phomapyrrolidones A-C, antitubercular alkaloids from the endophytic fungus Phoma sp. NRRL 46751.Synthesis of 3-(3-aryl-pyrrolidin-1-yl)-5-aryl-1,2,4-triazines that have antibacterial activity and also inhibit inorganic pyrophosphatase.New macrolide, lincosaminide and streptogramin B antibiotics.The nitroimidazooxazines (PA-824 and analogs): structure-activity relationship and mechanistic studies.QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity.Synthesis of Novel Hybrids Inspired from Bromopyrrole Alkaloids Inhibiting MMP-2 and -12 as Antineoplastic Agents.A novel combinatorial biocatalytic approach for producing antibacterial compounds effective against Mycobacterium tuberculosis (TB).Hapalindole-related alkaloids from the cultured cyanobacterium Fischerella ambigua.
P2860
Q27667438-6413E753-90FC-4F33-9AC2-BC9D81957403Q27667462-8F83A2A9-AADC-4C67-8FBB-866DDA944761Q28487748-4EEB2FB4-4564-4AE4-A2E7-F6F0BCA20B56Q29037987-B4803AC0-4BAA-4F19-8510-5616DF6C030FQ33223661-25F6FB91-5B72-44BE-BDBC-0AA239498A36Q33368530-03C2585E-D5AB-47C1-AA6F-EF8F3FB95368Q33532352-C5AE5AE8-1635-4C0E-8695-4D72691AE535Q33746313-D28CFBE2-C3F1-49DD-B84A-AD69DAD74E0EQ33894015-239CDA9C-F01B-46E1-B77A-3521B527C3C2Q34021206-3FFC3F28-26D2-4A4F-AFDD-C4E7CA81CD51Q34353151-5B6B13D3-1DB6-4077-8C43-E66710FFBC40Q34390401-DCB39D27-6ACD-4055-BF9B-6CB457F661D6Q34721591-D9CC04E2-49E7-4C33-9C08-506B7B24DC39Q34766701-D6BAAA6C-6957-4862-A0E8-C0CDCBDEC9CAQ34922070-6A8940FC-CC9D-48DC-9903-A76C6CB7DF33Q35019457-2FD1EFA6-B5CB-4DCF-A466-897DC1BE14A4Q35052626-5F093499-F23D-428E-95B3-170EAA1F613BQ35066117-02A69B81-7208-4FD4-A86C-D72BCE4A3AC3Q35106042-1E77B866-A63D-41B1-A61A-49FA04764D83Q35758962-D5FE7E86-88D3-4744-A1DF-7655D6EA8EF5Q36056408-EF366370-09A0-4522-9B67-71B6236D119CQ36149725-71D24F83-9466-439E-8AF6-74F7FC2B7F31Q36207357-A800DFDA-F867-4328-88EF-3C35CF9D6264Q36248387-E452B6F7-F727-4BB9-AF00-CF97A0A47736Q36351333-D0EE1E45-3563-4141-9790-4D963A1A213BQ36772385-BE154A1E-4675-4340-93E9-0D4B808BC512Q36990005-35EBEFAB-0FB5-40C5-AAD3-B911D74657F4Q37038925-1797E22C-E0CE-404E-A607-DD5136AA5E65Q37089655-59000F7D-1690-4647-8A27-6A7C0103D501Q37148764-13847195-2A93-493F-9AD9-CDB10576E34EQ37253845-A78BF25A-64FD-404D-898C-C14A2F2013C8Q37340569-4471D45A-3628-4253-9921-70CC38864596Q37495417-74EB78FD-2999-4024-AF66-1AB124591CCFQ37557968-03315D0C-C83B-4DF2-9626-897F9A75545AQ37774378-FC47111E-B78B-4BED-815C-B65A2E372CDFQ37855837-2F6924CC-D4B6-4F8B-A727-468B586DA1C4Q38743096-3DB0372A-B06B-4889-8CA9-A5ECE0D8E0DEQ38938374-D2FEBF04-A208-402D-A1C3-518489F7C24BQ39142098-D1E14A04-218A-45E8-BC6D-DF04DC58C4C4Q39641367-6809DB1E-CE98-4FE4-B70E-E7EDE2288A70
P2860
In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
In vitro and in vivo activitie ...... st Mycobacterium tuberculosis.
@ast
In vitro and in vivo activitie ...... st Mycobacterium tuberculosis.
@en
type
label
In vitro and in vivo activitie ...... st Mycobacterium tuberculosis.
@ast
In vitro and in vivo activitie ...... st Mycobacterium tuberculosis.
@en
prefLabel
In vitro and in vivo activitie ...... st Mycobacterium tuberculosis.
@ast
In vitro and in vivo activitie ...... st Mycobacterium tuberculosis.
@en
P2093
P2860
P1476
In vitro and in vivo activitie ...... st Mycobacterium tuberculosis.
@en
P2093
Huiwen Liu
Poonpilas Hongmanee
Zhaohai Zhu
P2860
P304
P356
10.1128/AAC.49.4.1447-1454.2005
P407
P577
2005-04-01T00:00:00Z